Authors: Berend, KR Pietrobon, R Moore, JO Dibernardo, L Harrelson, JM Scully, SP

Citation: Kr. Berend et al., Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection, J SURG ONC, 78(3), 2001, pp. 162-170

Authors: Ho, MK Tsang, CH Fontana, RE Parkin, SS Carey, KJ Pan, T MacDonald, S Arnett, PC Moore, JO

Citation: Mk. Ho et al., Study of magnetic tunnel junction read sensors, IEEE MAGNET, 37(4), 2001, pp. 1691-1694

Authors: Stone, RM Berg, DT George, SL Dodge, RK Paciucci, PA Schulman, PP Lee, EJ Moore, JO Powell, BL Baer, MR Bloomfield, CD Schiffer, CA

Citation: Rm. Stone et al., Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine, BLOOD, 98(3), 2001, pp. 548-553

Authors: Baer, MR Stewart, GC Dodge, RK Leget, G Sule, N Mrozek, K Schiffer, CA Powel, BL Kolitz, JE Moore, JO Stone, RM Davey, FR Carrol, AJ Larson, RA Bloomfield, CD

Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580

Authors: Lin, WC Moore, JO Mann, KP Traweek, ST Smith, C

Citation: Wc. Lin et al., Post transplant CD8+gamma delta T-cell lymphoma associated with human herpes virus-6 infection, LEUK LYMPH, 33(3-4), 1999, pp. 377-384

Authors: Byrd, JC Dodge, RK Carroll, A Baer, MR Edwards, C Stamberg, J Qumsiyeh, M Moore, JO Mayer, RJ Davey, F Schiffer, CA Bloomfield, CD

Citation: Jc. Byrd et al., Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered, J CL ONCOL, 17(12), 1999, pp. 3767-3775